18th International Symposium on Translational Research in Oncology
DCU researcher Denis Collins appeared alongside a wide range of international experts in the area from UCLA and Harvard Medical School, as DCU Chair of Translational Oncology Prof John Crown opened proceedings.
The symposium featured a presentations from Dr. Dennis J. Slamon, the 2019 Lasker Award winner and Director of Clinical/Translational Research at UCLA, and Dr. Douglas Hanahan, the 2025 winner of the Pezcoller Foundation–AACR International Award for Extraordinary Achievement in Cancer Research.
The three-day program covered cutting-edge topics including novel target identification in oncology, KRAS targeting in pancreaticobiliary cancers, neoadjuvant immunotherapy for lung cancer and mesothelioma, and the development of next-generation therapies such as PROTACs and CDK-4 inhibitors CCRT.
The symposium underscored Ireland's growing role as a hub for international cancer research collaboration and translational oncology advancements.